Lynne Terry (@lynneterry.bsky.social)

There's this: This: @US_FDA approves Alzheimer's drug Leqembi @CMSGov will foot 80% of $26,500 price tag. It's only for mild symptoms; can cause brain bleeds/kill you. Doesn't stop the disease either.

loading . . .

New Alzheimer’s Drugs Spark Hope for Patients and Cost Concerns for Medicare The Food and Drug Administration granted full approval to Leqembi, a new Alzheimer’s drug, on July 6, 2023. This updated policy watch focuses on the implications of Medicare coverage of the d… https://www.kff.org/policy-watch/new-alzheimers-drugs-spark-hope-for-patients-and-cost-concerns-for-medicare/#:~:text=At%20Leqembi's%20current%20%2426%2C500%20list,coinsurance%20requirement%20in%20traditional%20Medicare